In this study, fosinopril was predicted as the best ACE inhibitor (with maximum binding affinity for ACE after teprotide) to be used as a potentially therapeutic orally active drug (on the basis of Lipinski’s rule of five and BOILED-egg approach) for the treatment of hypertension. This evidence concerns the gene ACE and hypertensive disorder.